The Benefits of CombiPatch®

CombiPatch is a transdermal hormone therapy (HT) patch that contains both estrogen and progestin and is designed specifically for postmenopausal women who still have their uterus. When applied just twice a week, CombiPatch helps to treat moderate to severe hot flashes, night sweats, and vaginal dryness associated with menopause. You and your healthcare provider should talk regularly about whether you still need treatment with CombiPatch to control these problems. If you use CombiPatch only to treat menopausal changes in and around your vagina, talk with your healthcare provider about whether a topical vaginal product would be better for you.

CombiPatch is a small and discreet patch, and using its innovative Delivery Optimized Thermodynamics (DOT) Matrix technology, provides a continuous release of hormones through your skin and directly into your bloodstream. That means you can get effective symptom relief and a smaller daily dose of hormones than with HT pills. This difference does not mean that CombiPatch is safer or more effective than hormone therapy pills or other hormone therapies.

CombiPatch also provides options for you and your doctor. Learn about two dosing regimens, what bleeding patterns you can expect, and how you and your doctor can work together to meet your changing needs.

What's CombiPatch therapy really like?
How to use CombiPatch
What Makes CombiPatch Different?
Get details about the two dosing regimens and a clear discussion of what to expect.
Get step-by-step illustrated directions on how to apply your patch.
Get information about what makes CombiPatch different from other medications.

IMPORTANT SAFETY INFORMATION

  • Do not use estrogen alone or estrogens with progestins to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function)
  • Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots
  • Using estrogen alone or estrogens with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older.

COMBIPATCH® IMPORTANT SAFETY INFORMATION

INDICATION

COMBIPATCH® (estradiol/norethindrone acetate transdermal system) is a prescription medicine used to treat moderate to severe hot flashes associated with menopause; treat moderate to severe dryness, itching and burning in or around the vagina associated with menopause; and treat certain conditions in which a young woman’s ovaries do not produce enough estrogens naturally. If you use COMBIPATCH only to treat your dryness, itching and burning in or around the vagina, talk with your healthcare professional about whether a topical vaginal product would be better for you.

IMPORTANT SAFETY INFORMATION

  • Do not use estrogen alone or estrogens with progestins to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function)
  • Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots
  • Using estrogen alone or estrogens with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older.
  • Using estrogen-alone may increase your chances of getting cancer of the uterus (womb)
  • Using estrogen-alone may increase your chance of getting stroke or blood clots
  • You and your healthcare provider should talk regularly about whether you still need treatment with COMBIPATCH.

Do not use COMBIPATCH if you have had your uterus removed (hysterectomy). COMBIPATCH should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, blood clots, or liver problems; had a stroke or heart attack; have been diagnosed with a bleeding disorder; are allergic to COMBIPATCH or any of its ingredients; or think you may be, or know that you are, pregnant.

Before you take COMBIPATCH, tell your healthcare provider if you have unusual vaginal bleeding, have any other medical conditions, are going to have surgery or will be on bed rest, are breast feeding, and about all of the medicines you take.

You and your healthcare professional should talk regularly about whether you still need treatment with COMBIPATCH and whether you are taking the lowest dose that works for you.

The most common side effects that may occur with COMBIPATCH are breast pain, vaginal bleeding, and headache. These are not all the possible side effects of COMBIPATCH.

Click here for the Full Prescribing Information, including Boxed WARNING for CombiPatch.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

CombiPatch® is a registered trademark of Noven Pharmaceuticals, Inc.

MINIVELLE® (estradiol) transdermal system

INDICATION

MINIVELLE® (estradiol transdermal system) is a prescription medicine patch that contains estradiol (an estrogen hormone). MINIVELLE is used to reduce moderate to severe hot flashes due to menopause and to help prevent postmenopausal osteoporosis (thin weak bones). The 0.025 mg/day dose is only approved for the prevention of postmenopausal osteoporosis.

If you use MINIVELLE only to prevent osteoporosis from menopause, talk with your healthcare provider about whether a different treatment or medicine without estrogens might be better for you.

IMPORTANT SAFETY INFORMATION

  • Using estrogen-alone may increase your chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using MINIVELLE. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.
  • Do not use estrogen-alone or estrogen with progestins to prevent heart disease, heart attacks, strokes, or dementia (decline in brain function).
  • Using estrogen-alone may increase your chances of getting strokes or blood clots, while using estrogens with progestins may increase your changes of getting heart attacks, strokes, breast cancer, or blood clots.
  • Using estrogen-alone or estrogen with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older.
  • You and your healthcare provider should talk regularly about whether you still need treatment with MINIVELLE

MINIVELLE should not be used if you have unusual vaginal bleeding, currently have or have had certain cancers, had a stroke or heart attack, currently have or have had blood clots, currently have or have had liver problems, have been diagnosed with a bleeding disorder, are allergic to MINIVELLE or any of its ingredients, or think you may be pregnant.

Before you take MINIVELLE, tell your healthcare provider if you have unusual vaginal bleeding, have any other medical conditions, are going to have surgery or will be on bed rest, are breast feeding, and about all of the medicines you take.

MINIVELLE should be used at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks. You and your healthcare professional should talk regularly about whether you still need treatment with MINIVELLE.

The most common side effects that may occur with MINIVELLE are headache, breast tenderness, back and limb pain, common cold, upset stomach, nausea, inflammation of the sinuses and irregular vaginal bleeding or spotting.

These are not all the possible effects of MINIVELLE. Please read the Patient Information section within the full Prescribing Information before taking MINIVELLE. For more information ask your healthcare provider or pharmacist for advice about side effects.

Click here for the full Prescribing Information, including Boxed WARNING.

You are encouraged to report negative side effects of prescription drugs to the FDA.Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

CombiPatch ISI CombiPatch ISI CombiPatch ISI Full Prescribing Information for CombiPatch www.fda.gov/medwatch Full Prescribing Information for CombiPatch www.fda.gov/medwatch Full Prescribing Information for CombiPatch www.fda.gov/medwatch
Minivelle ISI Vivelle-Dot ISI Vivelle-Dot ISI
Indication and Important Safety Information for CombiPatch Indication and Important Safety Information for Vivelle-Dot
Close X
The site you are about to enter is intended specifically for U.S. healthcare professionals

Click continue if you are a U.S. healthcare professional.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site independently operated and not managed by Noven Pharmaceuticals. Noven assumes no responsibility for the content of the site.

Close X
The site you are about to enter is intended specifically for U.S. healthcare professionals

Click continue if you are a U.S. healthcare professional.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site operated by Noven Therapeutics, LLC.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site operated by Noven Pharmaceuticals, Inc., a partner with Novartis Pharmaceuticals Corporation in the joint venture Novogyne Pharmaceuticals.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site operated by Noven Therapeutics, LLC.

Close X
Need Help Finding CombiPatch®?

Noven is working diligently to improve product availability, but intermittent spot retail shortages of CombiPatch may continue for the remainder of 2016

The Pharmacy Locator Service (1-800-420-2719) may be able to identify a pharmacy that might have CombiPatch in stock. If you are unable to find a pharmacy that has Combi Patch in stock, please contact your healthcare provider.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site operated by Novartis Pharmaceuticals Corporation, a partner with Noven Pharmaceuticals, Inc. in the joint venture Novogyne Pharmaceuticals.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site operated by Novartis Pharmaceuticals Corporation, a partner with Noven Therapeutics, LLC.

Close X
Leaving the CombiPatch® Web Site

You are now leaving the CombiPatch Web site and moving to an external Web site operated by Noven Therapeutics, LLC.